While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF ... as tensions in the tech sector subsided. European stock pickers are exploring established sectors such as utilities ...

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

The board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on the 30th of April. This means the annual payment will be 1.6% of the current stock price ...

Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...

In a report released today, Matthew Weston from UBS maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of ...

Idrees Abbas / SOPA Images / LightRocket / Getty Images Shares of SpringWorks Therapeutics soared on Monday following a report that German medical firm Merck KGaA could acquire the company.

Merck KGaA sees forex-adjusted earnings growth of up to 8% this year Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...